18 results with keyword: 'computational biology acute myeloid leukemia cebpa abnormalities'
To compare different methods and to analyze the promoter array data, we made use of a dataset that was obtained from a ChIP of beta-estradiol induced C/EBPα in a
N/A
Maximum Size: 1 month of revenue data Compute Time: 3-10 min.. Compute Time
N/A
+: trisomy; ACAs: Acquired chromosomal abnormalities; AMKL: Acute megakaryoblastic leukemia; AML: Acute myeloid leukemia; del: deletion; der: derivative; DS: Down syndrome;
N/A
Comparison of light microscopic techniques for the diagnosis of the infection of the European flat oyster Ostrea edulis by the protozoan Bonamia ostreae.. Cochennec-Laureau
N/A
The aim of this study was to profile the spectrum of genetic mutations in acute myeloid leukemia (AML) patients co-occurring with CEBPA double mutation (CEBPA dm ).. Out of these,
N/A
Keywords: nanopore targeted sequencing; acute myeloid leukemia; mutational analysis; FLT3 internal tandem duplications; biallelic CEBPA mutations1. Recurring molecular lesions
N/A
Furthermore, the prognosis of patients with AML has been associated with CEBPA mRNA expression levels in patients with an intermediate- risk karyotype.. Significant
N/A
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk
N/A
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high- risk
N/A
ACAs: Additional cytogenetic abnormalities; aMCB: Array-proven high-resolution multicolor banding; AMKL: Acute megakaryoblastic leukemia; AML: Acute myeloid leukemia; DAPI: 4 ′
N/A
The results from the implementation of manual DR strategies for both IT equipment (server, storage) and site infrastructure (cooling) identified that similar data centers
N/A
childhood Acute Myeloid Leukemia; sAML, secondary Acute Myeloid Leukemia; AML, Acute Myeloid Leukemia; t-MN, therapy-related Myeloid Neoplasms; MPN, Myeloproliferative
N/A
• Understanding regulatory guidances and their level of enforcement is critical for not being under or over compliant. • Incorporate available predictive tools
N/A
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: indepen- dent favorable prognostic factor within NPM1 mutated patients. CEB- PA single mutation can be
N/A
Ph: Philadelphia chromosome; CML: chronic myeloid leukemia; ALL: acute lymphoblastic leukemia; AML: acute myeloid leukemia; MPAL: mixed‑pheno‑ type acute leukemia; TK: tyrosine
N/A
Port, M., et al., Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and
N/A
Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. Bakshi SR,
N/A
ACC: Adenoid cystic carcinoma; ALL: Acute lymphoblastic leukemia; AML: Acute myeloid leukemia; APL: Acute promyelocytic leukemia, cholangio cholangiocarcinoma; CML: Chronic
N/A